1006 The anti-IGF-IR antibody figitumumab (CP-751,871) is active in patients with lung adenocarcinoma undergoing epithelial-tomesenchymal transition

✍ Scribed by A. Gualberto; M.L. Hixon; M.P. Dolled-Filhart; J. Chistensen; D.L. Rimm; A.V. Lee; Y.F. Wang; M. Pollak; L.G. Paz-Ares; D.D. Karp

• Book ID: 119600060
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 68 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70299-x